YES Securities is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1015 in its research report dated October 24 2023.
Rossari Biotech Reports 38% PAT Growth in Q2 FY24 and Announces ₹178 Cr Capacity Expansion Plans freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Rossari Biotech Limited at the AGM, the shareholders approved the appointment of Ms. Esha Padmanabhan Achan as an Additional Director designated as Non-Executive, Independent Director with effect from.
Rossari Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 4,834.68 million compared.